Eliana Clark Intellia Therapeutics, Inc. (NTLA) insider trading activity
Eliana Clark is EVP, Chief Technical Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 71,470 shares of NTLA, which is worth approximately $1.02 Million. The most recent transaction as insider was on Jul 01, 2024, when has been sold 405 shares (Common Stock) at a price of $22.93 per share, resulting in proceeds of $9,286. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
71.5K
0%
3M change
58.31%
12M change
Total Value Held
$1.02 Million
Eliana Clark Transaction History
EC
Eliana Clark
EVP, Chief Technical Officer
Cambridge, MA